
STAT+: Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more
Top of the morning to you. And a fine one it is, despite the clouds enveloping the Pharmalot campus. Birds are chirping, neighbors are mulling about, and the official mascots are scurrying across the grounds in search of creatures to annoy. As for us, we …